|Articles|March 28, 2020

Recalls That Should Be on Your Radar—Week of March 22, 2020

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Guan’s Mushroom Co Issues Recall of Enoki Mushrooms Due to Listeria monocytogenes Contamination

Guan’s Mushroom Co has issued a recall of all cases of its 200g/7.05 ounce packages of Enoki Mushroom due to the potential to be contaminated with Listeria monocytogenes.

Listeria monocytogenes can cause serious, even deadly, infections in older adults, the immunocompromised, and young children. In healthy individuals, there are typically only short term symptoms like fever, severe headache, nausea, stiffness, diarrhea, and abdominal pain.

No adverse health events have been reported to date in connection with this problem.

The potential for contamination was noted during routine testing by State of California.

The products affected are enoki mushrooms from South Korea. The FDA began investigating an outbreak of Listeria associated with enoki mushrooms imported from South Korea which were sold by another firm earlier in March.

Read the recall statement.

Dr. Reddy's Laboratories Issues Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening

Dr. Reddy’s Laboratories Ltd. has issued a voluntary recall of 4 lots (ACB902, ACB903, ACB904, ACB905) of Phytonadione Injectable Emulsion USP, 10 mg/mL, Single-Dose Ampules to the hospital level. The recall is due to product complaints received about ampules breaking and shattering, upon opening, during compounding.

The firm has received reports of cuts in skin and lacerations to health care professionals. There is a possibility of flying glass resulting in either temporary or permanent injury.

Phytonadione injectable emulsion is indicated in coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by Vitamin K deficiency or interference with Vitamin K activity.

Read the recall statement.


Related to this article

New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
FAQ: Congenital Measles
Congenital measles is a serious infection that can occur when a pregnant woman contracts measles near delivery and transmits the virus across the placenta to her newborn. Here is more information around this rare form of the disease.